An oral liquid furosemide solution from Rosemont Pharmaceuticals has been approved for administration via gastrostomy tubes.

Frusol – indicated for conditions including oedema and hypertension – was the first furosemide solution to receive approval for use in nasogastric or percutaneous endoscopic tubes, Rosemont announced on July 6.

The company hailed the approval as a “major step forward” for patients that would remove the need to administer the medication via an unlicensed route or to manipulate solid doses for an unlicensed use.

“This [decision] will improve patient safety and reduce legal risks for healthcare professionals,” said product manager Chris Palmer.

Frusol oral solution comes in three strengths: 20mg/5ml, 40mg/5ml and 50mg/5ml. The NHS list price for the 20mg/5ml dose is £12.07.

To order, contact your wholesaler or create an online account at rosemontpharma.com